Free Newsletter
Nigeria calls Pfizer execs to trial
Nigeria v. Pfizer in the matter of a meningitis vaccine trial went back to court today, with a judge allowing the authorities there to summon Pfizer and nine company officials to the country to defend themselves. The summons aims to compel the execs to a hearing November 6.
Civil rights groups are all set to protest against the drug maker, which is criminally and civilly accused misconduct when it tried out its Trovan treatment during a 1996 meningitis epidemic. Eleven children participating in the trial died, and others ended up with permanent injuries. Pfizer denies wrongdoing, saying it answered pleas for help when it brought the experimental drug to Nigeria.
Trovan, of course, proved a safety risk when it was licensed by the FDA a few months after the Nigerian trial. Three years later, the agency restricted the drug because of possible liver damage.
- read the article from the International Business Times
- see this item from the Wall Street Journal
Related Articles:
Pfizer seeks dismissal of Nigeria lawsuit. Report
Trial deaths spur criminal charges against Pfizer. Report
Pfizer 'exploited' children in African trial. Report
Report: Pfizer 'exploited' children in African trial. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: